These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32986840)

  • 1. RE: Breast Cancer Mortality After Implementation of Organized Population-Based Screening in Norway.
    Zahl PH
    J Natl Cancer Inst; 2020 Nov; 112(11):1174. PubMed ID: 32986840
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of organized mammography screening on breast cancer mortality: A population-based cohort study in Norway.
    Møller MH; Lousdal ML; Kristiansen IS; Støvring H
    Int J Cancer; 2019 Feb; 144(4):697-706. PubMed ID: 30144028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer mortality in Norway after the introduction of mammography screening.
    Olsen AH; Lynge E; Njor SH; Kumle M; Waaseth M; Braaten T; Lund E
    Int J Cancer; 2013 Jan; 132(1):208-14. PubMed ID: 22532175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [All women should participate in the Norwegian Breast Cancer Screening Programme].
    Torgersen JGR; Andreassen T; Janbu T
    Tidsskr Nor Laegeforen; 2020 Jun; 140(9):. PubMed ID: 32549017
    [No Abstract]   [Full Text] [Related]  

  • 5. [Misleading and tendentious comments about information in the Norwegian Breast Cancer Screening Programme].
    Hofvind S; Mangerud G; Ursin G
    Tidsskr Nor Laegeforen; 2020 Apr; 140(6):. PubMed ID: 32321230
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening outcome for consecutive examinations with digital breast tomosynthesis versus standard digital mammography in a population-based screening program.
    Hovda T; Brandal SHB; Sebuødegård S; Holen ÅS; Bjørndal H; Skaane P; Hofvind S
    Eur Radiol; 2019 Dec; 29(12):6991-6999. PubMed ID: 31187221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of breast cancer mortality following mammography screening in Denmark and Norway.
    Kalager M; Løberg M; Bretthauer M; Adami HO
    Ann Oncol; 2014 Jun; 25(6):1137-43. PubMed ID: 24669012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of organized screening programs on breast cancer screening, incidence, and mortality in Europe.
    Guthmuller S; Carrieri V; Wübker A
    J Health Econ; 2023 Dec; 92():102803. PubMed ID: 37688931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer incidence trends in Norway and estimates of overdiagnosis.
    van Luijt PA; Heijnsdijk EA; van Ravesteyn NT; Hofvind S; de Koning HJ
    J Med Screen; 2017 Jun; 24(2):83-91. PubMed ID: 27754936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of breast cancer by prior screening results among women participating in BreastScreen Norway.
    Lilleborge M; Falk RS; Russnes H; Sauer T; Ursin G; Hofvind S
    Cancer; 2019 Oct; 125(19):3330-3337. PubMed ID: 31206638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast Cancer Mortality After Implementation of Organized Population-Based Breast Cancer Screening in Norway.
    Sebuødegård S; Botteri E; Hofvind S
    J Natl Cancer Inst; 2020 Aug; 112(8):839-846. PubMed ID: 31848605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summaries for patients: Overdiagnosis of invasive breast cancer with mammography screening.
    Ann Intern Med; 2012 Apr; 156(7):I58. PubMed ID: 22473444
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness of the Norwegian breast cancer screening program.
    van Luijt PA; Heijnsdijk EA; de Koning HJ
    Int J Cancer; 2017 Feb; 140(4):833-840. PubMed ID: 27861849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychological predictors of intention and avoidance of attending organized mammography screening in Norway: applying the Extended Parallel Process Model.
    Ivanova A; Kvalem IL
    BMC Womens Health; 2021 Feb; 21(1):67. PubMed ID: 33588809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of radiation-induced breast cancers due to biennial mammographic screening in women aged 50-69 years is minimal.
    Hauge IH; Pedersen K; Olerud HM; Hole EO; Hofvind S
    Acta Radiol; 2014 Dec; 55(10):1174-9. PubMed ID: 24311702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The information about mammography screening is not neutral].
    Zahl PH
    Tidsskr Nor Laegeforen; 2013 Aug; 133(15):1557-8. PubMed ID: 23970258
    [No Abstract]   [Full Text] [Related]  

  • 17. Breast cancer incidence trends in Norway--explained by hormone therapy or mammographic screening?
    Hofvind S; Sakshaug S; Ursin G; Graff-Iversen S
    Int J Cancer; 2012 Jun; 130(12):2930-8. PubMed ID: 21732346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of breast cancer screening in a population with high spontaneous coverage with mammography.
    Capodaglio G; Zorzi M; Tognazzo S; Greco A; Michieletto F; Fedato C; Montaguti A; Turrin A; Ferro A; Cinquetti S; Russo F; Corti MC; Rugge M; Fedeli U
    Tumori; 2018 Aug; 104(4):258-265. PubMed ID: 30079815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.
    Belpomme D; Irigaray P
    J Natl Cancer Inst; 2010 Apr; 102(7):506-7. PubMed ID: 20190186
    [No Abstract]   [Full Text] [Related]  

  • 20. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.
    Kalager M; Adami HO; Bretthauer M; Tamimi RM
    Ann Intern Med; 2012 Apr; 156(7):491-9. PubMed ID: 22473436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.